Compounds > 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole
Page last updated: 2024-09-02

5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole and vasoactive intestinal peptide

5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole has been researched along with vasoactive intestinal peptide in 1 studies

Compound Research Comparison

Studies
(5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole)		Trials
(5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole)		Recent Studies (post-2010)
(5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole)		Studies
(vasoactive intestinal peptide)		Trials
(vasoactive intestinal peptide)		Recent Studies (post-2010) (vasoactive intestinal peptide)
21801210,8731231,221

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bockaert, J; Kemp, DE; Sebben, M; Weiss, S1

Other Studies

1 other study(ies) available for 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole and vasoactive intestinal peptide

ArticleYear
Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons.
    European journal of pharmacology, 1986, Jan-21, Volume: 120, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenylyl Cyclases; Animals; Brain; Cerebral Cortex; Corpus Striatum; Cyclic AMP; Female; Fetus; Indoles; Ketanserin; Metergoline; Mice; Neurons; Piperidines; Pregnancy; Receptors, Serotonin; Tetrahydronaphthalenes; Vasoactive Intestinal Peptide

1986